Ocular Therapeutix (OCUL) Price to Sales (2014 - 2026)
Ocular Therapeutix's (OCUL) Price to Sales came in at 41.43 for Q2 2026, up 46.3% from 28.32 a year earlier and up 16.3% from the prior quarter.
Powered by 
Analysis
Ocular Therapeutix (OCUL) Price to Sales (2014 - 2026) Analysis & Trends
For FY2025, Ocular Therapeutix's Price to Sales stood at 50.46, up 138.7% from FY2024.
- Annual Price to Sales has increased for three consecutive years.
- In prior years, Ocular Therapeutix's Price to Sales was 21.14 in FY2024 (+247.0%), 6.09 in FY2023 (+44.6%), 4.21 in FY2022 (-65.7%) and 12.29 in FY2021 (-83.0%).
- Quarterly Price to Sales has run from a low of 4.21 in Q4 2022 to a high of 50.46 in Q4 2025 over five years.
- On a year-over-year basis, Price to Sales has increased in each of the last five quarters, with growth averaging 129.8% over the last eight quarters.
- The strongest year-over-year quarter for Price to Sales in the past five years was Q3 2024, with growth of 413.4%; the weakest was Q1 2022, with a decline of 86.4%.
- According to Business Quant data, Price to Sales for the three prior quarters was 35.63 (Q1 2026), 50.46 (Q4 2025) and 36.66 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 11.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.43 |
| Mar 31, 2026 | 35.63 |
| Dec 31, 2025 | 50.46 |
| Sep 30, 2025 | 36.66 |
| Jun 30, 2025 | 28.32 |
| Mar 31, 2025 | 19.57 |
| Dec 31, 2024 | 21.14 |
| Sep 30, 2024 | 22.18 |
| Jun 30, 2024 | 17.42 |
| Mar 31, 2024 | 23.53 |
| Dec 31, 2023 | 6.09 |
| Sep 30, 2023 | 4.32 |
| Jun 30, 2023 | 7.49 |
| Mar 31, 2023 | 7.90 |
| Dec 31, 2022 | 4.21 |
| Sep 30, 2022 | 6.43 |
| Jun 30, 2022 | 6.19 |
| Mar 31, 2022 | 7.70 |
| Dec 31, 2021 | 12.29 |
| Sep 30, 2021 | 19.87 |
API Access
Ocular Therapeutix Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();